Background: The Close-to-Me (CTM) program was launched to bring infusion therapies closer to veterans, reducing travel burden and improving access for rural veterans. We evaluated outcomes from the first 2 quarters of FY26, comparing our satellite CTM site to the main VA. Methods: We conducted a retrospective analysis of data from October 2025 to March 2026 using the CTM Dashboard. We compared unique patients, appointment completion, no-shows, safety events, and travel/cost savings.